Q32 Bio (QTTB) Non Operating Investment Income (2022)
Q32 Bio's (QTTB) quarterly Non Operating Investment Income came in at -$2.2 million in Q3 2022, down 60.1% quarter-over-quarter from -$1.4 million in Q2 2022.
Q32 Bio (QTTB) Non Operating Investment Income (2022) Analysis & Trends
Q32 Bio's Non Operating Investment Income history runs 1 years deep, the most recent figure standing at -$2.2 million for Q3 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Operating Investment Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | - |
| 10 | Q32 Bio | 215.94 Mn | 165.19 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2022 | -2.18 Mn |
| Sep 30, 2022 | -2.18 Mn |
| Jun 30, 2022 | -1.36 Mn |
| Jun 30, 2022 | -1.36 Mn |
| Mar 31, 2022 | -591,000.00 |
| Mar 31, 2022 | -591,000.00 |